Delivering Targeted Long-Lasting Sustained Release Retinal Treatments Using Novel Suprachoroidal Injection
Time: 8:30 am
day: Conference Day Two
Details:
- Minimally invasive suprachoroidal catheterization device for improved patient care
- Clinical trials updates on suprachoroidal device administering sustained release dexamethasone drug product
- Exploring drug formulation properties for successful retinal drug delivery via suprachoroidal injection
